Cargando…
2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment
BACKGROUND: Helicobacter pylori (H. pylori) infection is an infectious disease with a prevalence rate of up to 50% worldwide. It can cause indigestion, gastritis, peptic ulcer, and gastric cancer. H. pylori eradication treatment can effectively control disease progression and reduce the risk of the...
Autores principales: | Zhou, Liya, Lu, Hong, Song, Zhiqiang, Lyu, Bin, Chen, Ye, Wang, Jiyao, Xia, Jun, Zhao, Zhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106216/ https://www.ncbi.nlm.nih.gov/pubmed/36579940 http://dx.doi.org/10.1097/CM9.0000000000002546 |
Ejemplares similares
-
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood
por: Kato, Seiichi, et al.
Publicado: (2020) -
Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021) -
Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition)
por: Ding, Song-Ze, et al.
Publicado: (2022) -
KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Publicado: (2023) -
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Publicado: (2022)